Previously submitted to: JMIR Cancer (no longer under consideration since Mar 16, 2021)
Date Submitted: Jul 1, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effect of body mass index on cancer-specific survival in gastric cancer patients: A longitudinal retrospective analysis
ABSTRACT
Background:
The correlation between body mass index (BMI) and cancer survival has been studied, and obesity is known to be a risk factor for various types of cancer. Though the importance of health management for cancer survivors is increasing, few studies have been conducted to determine the correlation between weight change and cancer survival based on longitudinal data. Since gastric cancer is a malignancy of the gastrointestinal tract, post-operative weight change is an important indicator for the management of the patient post-surgery.
Objective:
In this study, we analyzed the effect of changes in BMI with time on survival in gastric cancer patients on cancer survival to propose the direction of cancer patient weight management.
Methods:
8,795 patients diagnosed with gastric cancer in single hospital between January 1, 1994, and December 31, 2014, were enrolled in the study, and follow-up data were collected from the records until March 2018. The patients were divided into three groups based on the criteria of tumor extension (i.e., localized gastric cancer, gastric cancer with lymph node (LN) metastasis without distant metastasis, gastric cancer with distant metastasis). The degree of BMI change was divided into three groups based on the linear regression slope (slope value ≥ 0.5, ≤ - 0.5 or |slope value| < 0.5). Cancer-specific death to five years from the day of diagnosis, according to changes in BMI was analyzed using the Cox model and log-rank test.
Results:
Of the total 8,795 patients, average slope of weight change was -0.17. Patients without distant metastasis (n = 7536) had the best prognosis in the mid-group, whereas patients with distant metastasis (n = 1259) had the best prognosis in the prognosis in the rapidly-gaining weight group. In patients with distant metastasis, rapidly-losing weight was associated with a significant increase in gastric cancer mortality risk (HR = 1.66, p < 0.001).
Conclusions:
The trend in weight change, rather than the weight at fixed time-points, must be considered during the management of the patient. It demonstrates the importance of weight management and nutritional support in gastric cancer patients. These findings may contribute as a basis for patient participation to improve gastric cancer survival.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.